In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Roxana Mehran
Speaker
Roxana Mehran
Roxana Mehran Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

Specialities : Interventional Cardiology , Acute Coronary Syndromes, Peripheral Vascular and Cerebrovascular Disease, Research Methodology, Valvular Heart Disease

Roxana Mehran, MD is an internationally renowned interventional cardiologist and clinical research expert in the field of cardiovascular disease. As Director of the Center for Interventional Cardiovascular Research and Clinical Trials at Mount Sinai, she has built a globally respected academic research center focused on developing randomized clinical trials, outcomes research projects and high impact academic publications. A prolific researcher, Dr. Mehran has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, and participates regularly in developing national clinical guidelines. She has authored more than 1000 peer-reviewed articles and is one of the most highly cited researchers in the field of cardiology. Dr. Mehran has founded numerous nationally and internationally recognized initiatives and organizations which have served to push the field of cardiology forward, improving the care of patients around the world.

39 presentations from this speaker

Q&A.

Event : ESC Congress 2020

  • Session : Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI
  • Speaker : K Huber (Vienna,AT), D Capodanno (Catania,IT), S James (Uppsala,SE), R Mehran (New York,US)
  • Organised by Radcliffe Cardiology, supported by AstraZeneca in the form of an educational grant

Short-term dual antiplatelet therapy is safe and effective after PCI - PRO.

Event : ESC Congress 2020

  • Session : Controversies in Antiplatelet Treatment: Is Short-Term Dual Antiplatelet Therapy Safe and Effective after PCI?
  • Speaker : R Mehran (New York,US)

Telemedicine in the COVID era.

Event : ESC Digital Health Week 2020

  • Session : Telemedicine in the COVID era
  • Speaker : M Cowie (London,GB), F Braunschweig (Stockholm,SE), R Mehran (New York,US), S Leonardi (Pavia,IT)

USA Perspective.

Event : ESC Digital Health Week 2020

  • Session : Telemedicine in the COVID era
  • Speaker : R Mehran (New York,US)

When to leave aspirin behind?

Event : ESC Congress 2020

  • Session : Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI
  • Speaker : R Mehran (New York,US)
  • Organised by Radcliffe Cardiology, supported by AstraZeneca in the form of an educational grant

Artificial intelligence; machine learning, and advanced imaging.

Event : ESC Congress 2019

  • Session : Cardiovascular innovation: the next frontier
  • Speaker : R Mehran (New York,US)

Intensive platelet inhibition - Have we reached the ceiling or are there options for further development?

Event : ESC Congress 2019

  • Session : Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results? (EBAC Accredited)
  • Speaker : L Wallentin (Uppsala,SE), R Mehran (New York,US), RF Storey (Sheffield,GB), C Cannon (Boston,US), S James (Uppsala,SE)
  • Supported by an unrestricted educational grant from AstraZeneca

Summary and close

Event : ESC Congress 2019

  • Session : Intensive platelet inhibition in acute coronary syndromes - Where are we a decade after PLATO study results? (EBAC Accredited)
  • Speaker : R Mehran (New York,US)
  • Supported by an unrestricted educational grant from AstraZeneca

The evolution of dual antiplatelets therapies/antithrombotic regimens in interventional cardiology: a thirty year journey

Event : ESC Congress 2019

  • Session : ESC Andreas Gr√ľntzig Lecture on Interventional Cardiology
  • Speaker : R Mehran (New York,US)

The power of artificial intelligence beyond imaging: is clinical reasoning over?

Event : ESC Congress 2019

  • Session : Big data in cardiovascular medicine: hope or hype?
  • Speaker : R Mehran (New York,US)

Twitter Influencers get social at #ESCCongress

Event : ESC Congress 2019

  • Session : Twitter Influencers get social at #ESCCongress
  • Speaker : C Gibson (Boston,US), R Mehran (New York,US), M Mamas (Stoke On Trent,GB)

Antithrombotic treatment of patients undergoing TAVI.

Event : ESC Congress 2018

  • Session : Prevention and treatment of bioprosthetic valve failure
  • Speaker : R Mehran (New York,US)

Discussant review - BASKET-SMALL 2

Event : ESC Congress 2018

  • Session : Hot Line Session 4
  • Speaker : R Mehran (New York,US)

In PCI, are female patients just like men?

Event : ESC Congress 2018

  • Session : The PCI Summit
  • Speaker : R Mehran (New York,US)

Revascularization of multivessel disease in STEMI - an algorithm for success.

Event : ESC Congress 2018

  • Session : Primary PCI in STEMI: doing things right when the pressure is on
  • Speaker : R Mehran (New York,US)

Characteristics and clinical outcomes in patients undergoing PCI by levels of high-density lipoproteins

Event : ESC Congress 2017

  • Session : Determinants of long-term post-PCI outcomes
  • Speaker : R Mehran (New York,US)

Discussion - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Event : ESC Congress 2017

  • Session : Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
  • Speaker : P Steg (Paris,FR), DJ Angiolillo (Jacksonville,US), S James (Uppsala,SE), R Mehran (New York,US)
  • Sponsored by AstraZeneca

Managing the patient undergoing coronary stenting.

Event : ESC Congress 2017

  • Session : Managing the patient with atrial fibrillation (AF) requiring cardiac intervention
  • Speaker : R Mehran (New York,US)
  • Sponsored by Bayer AG

Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Event : ESC Congress 2017

  • Session : Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
  • Speaker : R Mehran (New York,US), S James (Uppsala,SE)
  • Sponsored by AstraZeneca

Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Event : ESC Congress 2017

  • Session : Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention
  • Speaker : R Mehran (New York,US)
  • Sponsored by Bayer AG

Presentation of the awardee.

Event : ESC Congress 2017

  • Session : ESC Andreas Gr√ľntzig Lecture on Interventional Cardiology
  • Speaker : R Mehran (New York,US)

Session close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Event : ESC Congress 2017

  • Session : Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
  • Speaker : R Mehran (New York,US)
  • Sponsored by AstraZeneca

Summary and Close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Event : ESC Congress 2017

  • Session : Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
  • Speaker : R Mehran (New York,US)
  • Sponsored by AstraZeneca

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Event : ESC Congress 2017

  • Session : Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)
  • Speaker : R Mehran (New York,US)
  • Sponsored by AstraZeneca

Stable coronary artery disease: stress testing thrown to the lions - Positioning of the topic

Event : ESC Congress 2016

  • Session : Stable coronary artery disease: stress testing thrown to the lions
  • Speaker : R Mehran (New York,US)

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? Positioning of the topic

Event : ESC Congress 2016

  • Session : Thromboembolic prevention after TAVI: antiplatelets or anticoagulants?
  • Speaker : R Mehran (New York,US)

Impact of coronary calcification in female patients undergoing PCI: Results from a pooled analysis of 26 randomized trials

Event : ESC Congress 2015

  • Session : Coronary artery disease and comorbidities IV
  • Speaker : R Mehran (New York,US)

Predictors of dual antiplatelet therapy non-adherence after PCI: insights from the PARIS registry

Event : ESC Congress 2015

  • Session : Infarction acute phase STEMI V
  • Speaker : R Mehran (New York,US)

Revascularisation and invasive strategies

Event : ESC Congress 2015

  • Session : Stable angina
  • Speaker : R Mehran (New York,US)
  • ESC and the Lancet

Controversies from the FREEDOM trial.

Event : ESC Congress 2014

  • Session : Which diabetic patients are eligible for PCI?
  • Speaker : R Mehran (New York,US)

PRAMI.

Event : ESC Congress 2014

  • Session : Strategy trials: important or impossible?
  • Speaker : R Mehran (New York,US)

PROTECT: Discussant review

Event : ESC Congress 2014

  • Session : Clinical Trial Update Hot Line: Infarction, interventions and outcome
  • Speaker : R Mehran (New York,US)

Gender Data Forum: Safety and Efficacy of Drug-Eluting Stents in Women: An Individual Patient-Level Pooled Analysis of 26 Randomized Trials Including 11,557 Women

Event : ESC Congress 2013

  • Session : Clinical Trial Update Hot Line I: Updates on hypertension, heart failure and diabetes
  • Speaker : R Mehran (New York,US)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are